Is the increased risk for MAFLD patients to develop severe COVID-19 linked to perturbation of the gut-liver axis? - PubMed (original) (raw)

Comment

Is the increased risk for MAFLD patients to develop severe COVID-19 linked to perturbation of the gut-liver axis?

Gabriella Assante et al. J Hepatol. 2021 Feb.

No abstract available

Keywords: COVID-19; Gut-liver axis; Inflammation; Intestinal permeability; MAFLD; Obesity.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest The authors declare no conflicts of interest that pertain to this work. Please refer to the accompanying ICMJE disclosure forms for further details.

Comment on

References

    1. Ji D., Qin E., Xu J., Zhang D., Cheng G., Wang Y. Non-alcoholic fatty liver diseases in patients with COVID-19: a retrospective study. J Hepatol. 2020;73(2):451–453. - PMC - PubMed
    1. Zhou Y.J.Z., Wang K.I., Yan X.B., Sun H.D., Pan Q.F., Wang K.H. Younger patients with MAFLD are at increased risk of severe COVID-19 illness: a multicenter preliminary analysis. J Hepatol. 2020;73(3):719–721. - PMC - PubMed
    1. Pan L., Mu M., Yang P., Sun Y., Wang R., Yan J. Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicenter study. Am J Gastroenterol. 2020;115(5):766–773. - PMC - PubMed
    1. Xiao F., Tang M., Zheng X., Liu Y., Li X., Shan H. Evidence for gastrointestinal infection of SARS-CoV-2. Gastroenterology. 2020;158(6):1831–1833.e3. - PMC - PubMed
    1. Giamarellos-Bourboulis E.J., Netea M.G., Rovina N., Akinosoglou K., Antoniadou A., Antonakos N. Complex immune dysregulation in COVID-19 patients with severe respiratory failure. Cell Host Microbe. 2020;27(6):992–1000.e3. - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources